Acute ischemic stroke
Conditions
Interventions
Treatment group:Electroneedle
Control group:Fake electroneedle
Sponsors
Chongqing Hospital of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1.Patients with ischemic stroke who have been ill for 3 to 14 days; 2. Diagnosed in accordance with the diagnostic criteria for large artery atherosclerotic cerebral infarction in TOAST; 3.Age: 18-80 years old; 4.The mRS Score before stroke is =1. 5.The NIHSS score is between 4 and 20 (when the NIHSS score is 4, the sum of the motor function scores of the upper and lower limbs is =2 points). 6. Those who understand the trial and sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1.Neuroimaging examinations (CT/MRI) suggest patients with intracranial hemorrhagic diseases (such as hemorrhagic stroke, epidural hematoma, intracranial hematoma, ventricular hemorrhage, subarachnoid hemorrhage, etc.), brain tumors, brain trauma, etc. 2. There is a history of bleeding in important organs within one month (such as a history of cerebral hemorrhage, gastrointestinal bleeding, etc.); 3. For those with severe liver or kidney dysfunction: alanine aminotransferase (ALT) or aspartate aminotransferase (AST) > 2.0 times the upper limit of the normal value, and/or other known liver diseases such as acute or chronic hepatitis, liver cirrhosis, etc. Serum creatinine >2.0×ULN, and/or known severe renal insufficiency disease; 4. Those with severe aphasia, deafness, severe cognitive impairment to the extent that they are unable to communicate normally; 5. Patients with other mental disorders who are unable or unwilling to cooperate; 6. Patients with contraindications to acupuncture (Acupuncture should not be performed immediately when extremely hungry, fatigued, or under high mental stress; acupuncture should not be performed on areas of the skin with infections, sores, scars, or tumors; acupuncture should not be performed on areas with bleeding disorders or spontaneous bleeding, or when the bleeding is difficult to stop after injury.) ; 7. Those who suffer from other life-threatening serious diseases (such as malignant tumors, serious diseases of the blood, digestive or other systems, etc.) and have an expected survival time of no more than 3 months; 8. Those who have participated in other clinical trials within the past three months or are currently participating in other clinical trials; 9. Women who are pregnant or planning to become pregnant; 10. Other circumstances that the researcher deems unsuitable for participation in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Modified Rankin Score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Modified Barthel Index;National Institute of Health Stroke Scale;Simplified Fugl-Meyer Motor Function Scale;Stroke-Specific Quality of Life Scale;Standard Swallowing Assessment;Water Swallowing Test;Montreal Cognitive Assessment;Modified Rankin Score;The occurrence of stroke recurrence events; | — |
Countries
China
Contacts
Public ContactTang Jun
Chongqing Hospital of Traditional Chinese Medicine
Outcome results
None listed